Cargando…

Intestinal biopsy is not always required to diagnose celiac disease: a retrospective analysis of combined antibody tests

BACKGROUND: The objective of this study was to compare celiac disease (CD)– specific antibody tests to determine if they could replace jejunal biopsy in patients with a high pretest probability of CD. METHODS: This retrospective study included sera from 149 CD patients and 119 controls, all with int...

Descripción completa

Detalles Bibliográficos
Autores principales: Bürgin-Wolff, Annemarie, Mauro, Buser, Faruk, Hadziselimovic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563615/
https://www.ncbi.nlm.nih.gov/pubmed/23343249
http://dx.doi.org/10.1186/1471-230X-13-19
_version_ 1782258225771446272
author Bürgin-Wolff, Annemarie
Mauro, Buser
Faruk, Hadziselimovic
author_facet Bürgin-Wolff, Annemarie
Mauro, Buser
Faruk, Hadziselimovic
author_sort Bürgin-Wolff, Annemarie
collection PubMed
description BACKGROUND: The objective of this study was to compare celiac disease (CD)– specific antibody tests to determine if they could replace jejunal biopsy in patients with a high pretest probability of CD. METHODS: This retrospective study included sera from 149 CD patients and 119 controls, all with intestinal biopsy. All samples were analyzed for IgA and IgG antibodies against native gliadin (ngli) and deamidated gliadin peptides (dpgli), as well as for IgA antibodies against tissue transglutaminase and endomysium. RESULTS: Tests for dpgli were superior to ngli for IgG antibody determination: 68% vs. 92% specificity and 79% vs. 85% sensitivity for ngli and dpgli, respectively. Positive (76% vs. 93%) and negative (72% vs. 83%) predictive values were also higher for dpgli than for ngli. Regarding IgA gliadin antibody determination, sensitivity improved from 61% to 78% with dpgli, while specificity and positive predictive value remained at 97% (P < 0.00001). A combination of four tests (IgA anti-dpgli, IgG anti-dpgli, IgA anti- tissue transglutaminase, and IgA anti-endomysium) yielded positive and negative predictive values of 99% and 100%, respectively and a likelihood ratio positive of 86 with a likelihood ratio negative of 0.00. Omitting the endomysium antibody determination still yielded positive and negative predictive values of 99% and 98%, respectively and a likelihood ratio positive of 87 with a likelihood ratio negative of 0.01. CONCLUSION: Antibody tests for dpgli yielded superior results compared with ngli. A combination of three or four antibody tests including IgA anti-tissue transglutaminase and/or IgA anti- endomysium permitted diagnosis or exclusion of CD without intestinal biopsy in a high proportion of patients (78%). Jejunal biopsy would be necessary in patients with discordant antibody results (22%). With this two-step procedure, only patients with no CD-specific antibodies would be missed.
format Online
Article
Text
id pubmed-3563615
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35636152013-02-08 Intestinal biopsy is not always required to diagnose celiac disease: a retrospective analysis of combined antibody tests Bürgin-Wolff, Annemarie Mauro, Buser Faruk, Hadziselimovic BMC Gastroenterol Research Article BACKGROUND: The objective of this study was to compare celiac disease (CD)– specific antibody tests to determine if they could replace jejunal biopsy in patients with a high pretest probability of CD. METHODS: This retrospective study included sera from 149 CD patients and 119 controls, all with intestinal biopsy. All samples were analyzed for IgA and IgG antibodies against native gliadin (ngli) and deamidated gliadin peptides (dpgli), as well as for IgA antibodies against tissue transglutaminase and endomysium. RESULTS: Tests for dpgli were superior to ngli for IgG antibody determination: 68% vs. 92% specificity and 79% vs. 85% sensitivity for ngli and dpgli, respectively. Positive (76% vs. 93%) and negative (72% vs. 83%) predictive values were also higher for dpgli than for ngli. Regarding IgA gliadin antibody determination, sensitivity improved from 61% to 78% with dpgli, while specificity and positive predictive value remained at 97% (P < 0.00001). A combination of four tests (IgA anti-dpgli, IgG anti-dpgli, IgA anti- tissue transglutaminase, and IgA anti-endomysium) yielded positive and negative predictive values of 99% and 100%, respectively and a likelihood ratio positive of 86 with a likelihood ratio negative of 0.00. Omitting the endomysium antibody determination still yielded positive and negative predictive values of 99% and 98%, respectively and a likelihood ratio positive of 87 with a likelihood ratio negative of 0.01. CONCLUSION: Antibody tests for dpgli yielded superior results compared with ngli. A combination of three or four antibody tests including IgA anti-tissue transglutaminase and/or IgA anti- endomysium permitted diagnosis or exclusion of CD without intestinal biopsy in a high proportion of patients (78%). Jejunal biopsy would be necessary in patients with discordant antibody results (22%). With this two-step procedure, only patients with no CD-specific antibodies would be missed. BioMed Central 2013-01-23 /pmc/articles/PMC3563615/ /pubmed/23343249 http://dx.doi.org/10.1186/1471-230X-13-19 Text en Copyright ©2013 Bürgin-Wolff et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bürgin-Wolff, Annemarie
Mauro, Buser
Faruk, Hadziselimovic
Intestinal biopsy is not always required to diagnose celiac disease: a retrospective analysis of combined antibody tests
title Intestinal biopsy is not always required to diagnose celiac disease: a retrospective analysis of combined antibody tests
title_full Intestinal biopsy is not always required to diagnose celiac disease: a retrospective analysis of combined antibody tests
title_fullStr Intestinal biopsy is not always required to diagnose celiac disease: a retrospective analysis of combined antibody tests
title_full_unstemmed Intestinal biopsy is not always required to diagnose celiac disease: a retrospective analysis of combined antibody tests
title_short Intestinal biopsy is not always required to diagnose celiac disease: a retrospective analysis of combined antibody tests
title_sort intestinal biopsy is not always required to diagnose celiac disease: a retrospective analysis of combined antibody tests
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563615/
https://www.ncbi.nlm.nih.gov/pubmed/23343249
http://dx.doi.org/10.1186/1471-230X-13-19
work_keys_str_mv AT burginwolffannemarie intestinalbiopsyisnotalwaysrequiredtodiagnoseceliacdiseasearetrospectiveanalysisofcombinedantibodytests
AT maurobuser intestinalbiopsyisnotalwaysrequiredtodiagnoseceliacdiseasearetrospectiveanalysisofcombinedantibodytests
AT farukhadziselimovic intestinalbiopsyisnotalwaysrequiredtodiagnoseceliacdiseasearetrospectiveanalysisofcombinedantibodytests